Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1728021PMC
http://dx.doi.org/10.1136/gut.47.2.307DOI Listing

Publication Analysis

Top Keywords

colonic reparative
4
reparative cell
4
cell lineage
4
lineage discovered?
4
colonic
1
cell
1
lineage
1
discovered?
1

Similar Publications

Article Synopsis
  • * The study revealed that MnNi@PVP significantly improved UC symptoms by reducing the disease activity index (DAI) and lowering inflammatory markers through the inactivation of the TLR4 pathway and macrophages.
  • * Moreover, MnNi@PVP aids in repairing intestinal barrier proteins and can specifically target inflamed tissues due to its negative charge, enhancing its therapeutic potential for UC.
View Article and Find Full Text PDF

Neoadjuvant chemotherapy combined with bevacizumab is used to treat colorectal cancer (CRC) patients by targeting tumor and vascular cells. However, it is known that other cells in the tumor microenvironment (TME) also change in response to this treatment. To investigate the changes in TME subpopulations in response to neoadjuvant FOLFOX6 plus bevacizumab, we studied pre- and post-treatment CRC tissues in four patients using single-cell RNA sequencing (scRNA-seq).

View Article and Find Full Text PDF

Macrophage activation plays a central role in the development of atherosclerotic plaques. Interaction with oxidized low-density lipoprotein (oxLDL) leads to macrophage differentiation into foam cells and oxylipin production, contributing to plaque formation. 7-Ketocholesterol (7KC) is an oxidative byproduct of cholesterol found in oxLDL particles and is considered a factor contributing to plaque progression.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of Hochuekkito (TJ-41), a Japanese herbal medicine, on inflammation and nutritional status in cancer patients, particularly focusing on malnutrition and muscle loss (sarcopenia).
  • Researchers analyzed 99 patients over 3 months, observing a significant reduction in the inflammatory marker C-reactive protein (CRP) in those with gastrointestinal cancer, especially in patients with metastatic disease.
  • The findings suggest that TJ-41 could be beneficial as a complementary treatment for gastrointestinal cancer by potentially reducing inflammation and helping manage muscle loss.
View Article and Find Full Text PDF

Short- and long-term outcomes of surgical treatment for inguinal lymph node metastasis in rectal and anal canal adenocarcinoma.

Colorectal Dis

July 2024

Study Group for Inguinal Lymph Node Metastasis from Colorectal Cancer by the Japanese Society for Cancer of the Colon and Rectum, Tokyo, Japan.

Aim: The significance of lymphadenectomy and its indications in patients with inguinal lymph node metastasis (ILNM) of anorectal adenocarcinoma is unclear. This study aimed to clarify the surgical outcomes and prognostic factors of inguinal lymphadenectomy for ILNM.

Method: This study included patients who underwent surgical resection for ILNM of rectal or anal canal adenocarcinoma with pathologically positive metastases between 1997 and 2011 at 20 participating centres in the Study Group for Inguinal Lymph Node Metastasis from Colorectal Cancer organized by the Japanese Society for Cancer of the Colon and Rectum.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!